Since some tumor cells can unexpectedly survive the activation of caspases, and tumor suppressor proteins that activate caspase-independent PCcD are commonly mutated in human cancer, the alternative cell death pathways are gaining increasing interest among cancer researchers. This evidence concerns the gene TCHP and neoplasm.